Nature GeneticsGenomicsPeer-reviewed journal article
Integrative analyses of splicing in the aging brain: role in susceptibility to Alzheimer’s Disease
Towfique RajiD, Yang LiiD, Garrett T. Wong, Jack HumphreyiD, Minghui WangiD, Satesh Ramdhani, Ying‐Chih WangiD, Bernard NgiD, Ishaan GuptaiD, Vahram H. HaroutunianiD, Eric E. SchadtiD, Tracy L. Young‐PearseiD, Sara MostafaviiD, Bin ZhangiD, Pamela B. SklariD, David Alan BennettiD, Philip L. De JageriD
Abstract
We use deep sequencing to identify sources of variation in mRNA splicing in the dorsolateral prefrontal cortex (DLFPC) of 450 subjects from two prospective cohort studies of aging. Hundreds of aberrant pre-mRNA splicing events are reproducibly associated with Alzheimers Disease (AD). We also generate a catalog of splicing quantitative trait loci (sQTL) effects in the human cortex: splicing of 3,198 genes is influenced by genetic variation. sQTLs are enriched among those variants influencing DNA methylation and histone acetylation. In assessing known AD loci, we report that altered splicing is the mechanism for the effects of the PICALM, CLU, and PTK2B susceptibility alleles. Further, we leverage our sQTL catalog to identify genes whose aberrant splicing is associated with AD and mediated by genetics. This transcriptome-wide association study identified 21 genes with significant associations, many of which are found in AD GWAS loci, but 8 are in novel AD loci, including FUS, which is a known amyotrophic lateral sclerosis (ALS) gene. This highlights an intriguing shared genetic architecture that is further elaborated by the convergence of old and new AD genes in autophagy-lysosomal-related pathways already implicated in AD and other neurodegenerative diseases. Overall, this study of the aging brains transcriptome provides evidence that dysregulation of mRNA splicing is a feature of AD and is, in some genetically-driven cases, causal.
- organism: human
- assay: bulk RNA-seq
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 419
- FWCI
- 15.91
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Allele-specific splicing modulates protein isoforms and Alzheimer's risk
Alison J. King, Kofi Amoah, … Xinshu Grace Xiao·Genome ResearchPeer-reviewed·Jun 1, 2026
- Mapping genetic effects on splicing in ten thousand post-mortem brain samples reveals novel mediators of neurological disease risk
Aline Réal, Kailash BP, … David A. Knowles·medRxiv·Sep 25, 2025
- Tau-mediated Disruption of the Spliceosome Triggers Cryptic RNA-splicing and Neurodegeneration in Alzheimer’s Disease
Yi‐Chen Hsieh, Caiwei Guo, … Joshua M Shulman·Cell ReportsPeer-reviewed·Oct 1, 2019
- Genome- and Transcriptome-wide Splicing Associations with Problematic Alcohol Use and Alcohol Use Disorder
Spencer B. Huggett, Ami Sala Ikeda, … Rohan H. C. Palmer·bioRxiv·Mar 31, 2021
- TDP-43 toxic gain of function links ALS, FTD and Alzheimers Disease through splicing dysregulation
Welmoed van Zuiden, Thea Deborah Meimoun, … Eran Hornstein·bioRxiv·Apr 20, 2025
- Long-read transcriptomic identification of synaptic adaptation to amyloid pathology in the App(NL-G-F) knock-in mouse model of the earliest phase of Alzheimer's disease
Ümran Yaman, Gareth T. Banks, … Dervis A. M. Salih·bioRxiv·Aug 10, 2024